Search clinical trials for: Antipsychotic Agents

Total 188523 results

Centre for Addiction and Mental Health
Pfizer

Completed

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Schizophrenia | Schizoaffective Disorder

Canada
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy

Major Depressive Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.

Schizophrenia | Schizoaffective Disorders
Teva Pharmaceuticals USA

Completed

Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions

Healthy

Canada
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania

Bipolar Disorder | Cannabis-Related Disorder

United States
Emalex Biosciences Inc.
Psyadon Pharma

Terminated

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Lesch-Nyhan Disease | Self-injurious Behavior

Spain, United States
All India Institute of Medical Sciences, Bhubaneswar

Completed

Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia

Treatment Resistant Schizophrenia

India
William Ondo, MD
Restless Legs Syndrome Foundation

Unknown

Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist (RLS-Ecopipam)

Restless Legs Syndrome | Augmentation

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Migraine (in Clinic)

Migraine

United States
Qilu Pharmaceutical (Hainan) Co., Ltd.

Not yet recruiting

A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.

PONV
Shanghai Mental Health Center

Unknown

Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia

Schizophrenia | Negative Symptom | Amisulpride | Gut Microbiomes
Mclean Hospital
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

An Investigation of Early Life Stress and Depression

Major Depressive Disorder (MDD) | History of Childhood Sexual Abuse (CSA)

United States
National Institute on Drug Abuse (NIDA)

Completed

Risperidone for the Treatment of Cocaine Dependence - 7

Cocaine-Related Disorders

United States
Birte Glenthoj
Rigshospitalet, Denmark; UMC Utrecht; Glostrup University Hospital, Copenhagen; Copenhagen Hospital Corporation and other collaborators

Completed

Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Denmark
Imperial College London
University College, London; University of Manchester

Completed

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia (AMICUS)

Schizophrenia

United Kingdom
Damanhour University

Completed

Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy Volunteers (SUL)

Healthy

Egypt
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
University of Alabama at Birmingham
Janssen Pharmaceutica

Completed

Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

Borderline Personality Disorder

United States
Northwell Health

Withdrawn

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform | Psychosis Not Otherwise Specified (NOS)

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Schizotypal Personality Disorder Risperidone

Schizotypal Personality Disorder
Massachusetts General Hospital
Stanley Medical Research Institute

Completed

Risperidone Augmentation in Patients With Schizophrenia

Schizophrenia

United States
The Medical Research Network
Pfizer; Liebowitz, Michael R., M.D.

Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Major Depressive Episode | Bipolar II Disorder

United States
Lindner Center of HOPE
University of Cincinnati; Janssen Pharmaceuticals

Completed

Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

Bipolar Disorder | Anxiety Disorder

United States
Manhattan Psychiatric Center
Pfizer

Completed

Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

Attention Deficit and Disruptive Behavior Disorders
Janssen Pharmaceutical K.K.

Terminated

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Dementia | Alzheimer's Disease
Janssen, LP

Completed

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen-Ortho Inc., Canada

Completed

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Bipolar Disorder | Manic Disorder
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); Pfizer

Completed

Ziprasidone in Early Onset Schizophrenia Spectrum Disorders (ZEOSS)

Schizophrenia

United States
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
University of British Columbia

Completed

CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

Psychosis, Schizophrenia

Canada
National Center for Research Resources (NCRR)
Yale University

Completed

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Tourette Syndrome
Mitsubishi Tanabe Pharma Corporation

Completed

Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
AstraZeneca

Terminated

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis (FAST)

Psychotic Disorders | Schizophrenia | Bipolar Disorder

Sweden
Centre for Addiction and Mental Health

Recruiting

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Emalex Biosciences Inc.
Psyadon Pharma

Completed

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Tourette's Syndrome

United States
National Institute on Drug Abuse (NIDA)
VA Boston Healthcare System

Terminated

Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Risperidone Treatment in Dually-Diagnosed Individuals - 2

Cocaine-Related Disorders

United States
Indiana University
AstraZeneca

Completed

A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients

Panic Disorder

United States
PharmaNeuroBoost N.V.

Completed

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Schizoaffective Disorder | Chronic Schizophrenia

Belgium
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Columbia University; New York State...

Completed

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

Schizophrenia Spectrum and Other Psychotic Disorders

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

Schizophrenia

Hungary
Bronx Psychiatric Center
Pfizer; Buffalo Psychiatric Center; Rochester Psychiatric Center

Completed

Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

Disruptive Behavior Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Depressive Disorder | Depression | Depressive Disorder, Major
Janssen, LP

Completed

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder

Search clinical trials for: Antipsychotic Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations